Drug and alcohol testing: An expanding market
The demand for drug and alcohol testing in the UK is at an all-time high and the market is growing rapidly, says Livingstone's Barry Sheehan...
List view / Grid view
Articles
Supply chains key to Life Sciences transformation, says new report
Life Sciences and Healthcare supply chains need transformation to support the increasing cost pressures and consumer demands for new and more convenient, affordable care models…
Outsourcing: Current trends in the CDMO sector
Patheon’s Joe Principe examines current trends in outsourcing, highlighting the importance of investment in CDMO partnerships...
Separations & Purifications In-Depth Focus 2017
In this Separations & Purifications In-Depth Focus: Experts from Leo Pharma explain how they use an MHC 2D-LC system in their analytical troubleshooting laboratory and how it can be applied to solve key tasks in the lab. Plus, Dave Elder explains how guidance for mutagenic impurities has necessitated control of…
Looking for life sciences opportunities in a post-Brexit world – part 2
A year on from the Brexit referendum, Dr Penny Owen outlines the potential risks this vote could have on the life science industry and how to prepare for leaving the EU...
Freeze-dried formulations: a new perspective on reformulating naloxone
Opioid overdose in the US and in Europe is on the rise, and the role of prescription-sourced drugs such as oxycodone cannot be underestimated...
Raman spectroscopy as a blood glucose monitoring tool
European Pharmaceutical Review, Issue 2 of 2016 focused on nanotechnology and stem cell technology to monitor glucose and prevent diabetes, respectively. The aim of this review is to sensitise the technology innovators in this field by providing expert opinions on biomedical products and technologies that have come the closest so…
Raman Spectroscopy In-Depth Focus
In this Raman Spectroscopy In-Depth Focus: Subvisible particle identification in protein-based formulations by Raman spectroscopy; Raman spectroscopy as a blood glucose monitoring tool...
The regulatory acceptance of rapid microbiological methods
In the last issue of European Pharmaceutical Review (vol 22, issue 2), Jeanne Moldenhauer suggested the pharmaceutical industry has moved at a “snail’s pace” in terms of implementing rapid microbiological methods (RMM).
Microorganisms and a new horizon of scientific discoveries
The simplest form of life is composed of single-celled microorganisms which are thought to have appeared around 3.5x109 years ago.1 Interestingly, evidence has shown that chloroplasts and mitochondria were once free-living microorganisms that became incorporated into eukaryotic cells and eventually became energy-producing organelles.1 Biodiversity enables microorganisms to survive in extreme…
Regulation of orphan drugs within the EU
Simply put, an orphan drug is indicated for the treatment of a very rare disease. Such diseases are often due to genetic defects and therefore children and newborns are affected to a great extent1.
Microfluidic techniques for cancer therapies
Perhaps the most significant challenge in all of medicine is the need for more effective treatments for cancer, which causes one of every four deaths in the United States and bears a direct cost to our healthcare system of close to $100bn annually.
Guide To Testing Services
Welcome to European Pharmaceutical Review’s Guide to Testing Services, the second in our new series of ‘Guide to …’ supplements. In this edition, five leading testing service suppliers explain how their service offering meets current industry needs...
Subvisible particle identification in protein-based formulations by Raman spectroscopy
Subvisible particles in protein-based formulations can have different origins. Particles can be extrinsic (unexpected foreign material), intrinsic (from the production environment or primary packaging), and inherent (from the formulation). It is important that inherent particles (protein agglomerates) are distinguished from the other two types and that the extrinsic and intrinsic…
Separation and purification applications for mutagenic impurities
Classically, isolation of key intermediates and the resultant active pharmaceutical ingredient (API) has formed the basis of clean up and purification strategies within the pharmaceutical industry...
